Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?

Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

(2022) Anna-Karin Smekal et al.   Scientific Reports

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

(2020) Mohd H. Abdul-Aziz et al.   INTENSIVE CARE MEDICINE

Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?

(2018) Anouk E. Muller et al.   DRUGS

MIC-based dose adjustment: facts and fables

(2017) Johan W Mouton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients

(2016) J. Petersson et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied

(2016) H. Woksepp et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy

(2016) Anders Perner et al.   INTENSIVE CARE MEDICINE

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION